ACRX - AcelRx Pharmaceuticals Q4 2022 Earnings Preview
2023-03-29 14:10:56 ET
- AcelRx Pharmaceuticals ( NASDAQ: ACRX ) is scheduled to announce Q4 earnings results on Thursday, March 30th, after market close.
- The consensus EPS Estimate is -$0.10 and the consensus Revenue Estimate is $4.5M (vs. $0.2M in prior year quarter).
For further details see:
AcelRx Pharmaceuticals Q4 2022 Earnings Preview